{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:01:01Z","timestamp":1753887661672,"version":"3.41.2"},"reference-count":18,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:p>A 17-year-old female was diagnosed with inflammatory bowel disease and started on infliximab. A few weeks after starting infliximab, she developed a recurrence of daily fevers associated with an intermittent dry cough, which worsened over the course of a month. A chest radiograph, abdominal ultrasound, and computed tomography scan of the chest and abdomen revealed a heterogeneous spleen with multiple hyperechoic areas, tiny splenic micronodules, and diffuse micronodularity throughout the lungs. She was transferred to a tertiary care hospital because of hypotension, new oxygen requirements, and ongoing fever. Her bloodwork on presentation to tertiary care revealed pancytopenia and elevated inflammatory markers; she had splenomegaly on MRI. As her clinical picture evolved, she continued to have persistent fevers and anorexia despite ongoing management. Infectious diseases, rheumatology, and gastroenterology were consulted to guide the evaluation and management of this patient\u2019s complex clinical course.<\/jats:p>","DOI":"10.1542\/peds.2024-067175","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T08:06:16Z","timestamp":1731053176000},"source":"Crossref","is-referenced-by-count":1,"title":["Prolonged Fever After the Treatment of Ulcerative Colitis in an Adolescent"],"prefix":"10.1542","volume":"154","author":[{"given":"Sarah L.","family":"Silverberg","sequence":"first","affiliation":[{"name":"aDivision of Infectious Diseases, Department of Paediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah M.","family":"Levy","sequence":"additional","affiliation":[{"name":"bDivision of Rheumatology, Department of Paediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brie A.","family":"Yama","sequence":"additional","affiliation":[{"name":"cDivision of Paediatric Medicine, Department of Paediatrics, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Church","sequence":"additional","affiliation":[{"name":"dDivision of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Hospital for Sick Children and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irini","family":"Sereti","sequence":"additional","affiliation":[{"name":"eDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)\/NIH, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Kitai","sequence":"additional","affiliation":[{"name":"aDivision of Infectious Diseases, Department of Paediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"5","key":"2024121614380842800_B1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/QCO.0b013e3283306712","article-title":"Intestinal tuberculosis","volume":"22","author":"Donoghue","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"2024121614380842800_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jctube.2018.04.003","article-title":"Tuberculosis of the gastrointestinal tract and associated viscera","volume":"12","author":"Malikowski","year":"2018","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"2024121614380842800_B3","first-page":"20","article-title":"Rifampicin-induced thrombocytopenia: a case report and short review of the literature","volume":"10","author":"Koumpis","year":"2021","journal-title":"Eur Med J"},{"issue":"4","key":"2024121614380842800_B4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijtb.2023.04.029","article-title":"Anti-tubercular therapy (ATT) induced thrombocytopenia: a systematic review","volume":"70","author":"Kaur","year":"2023","journal-title":"Indian J Tuberc"},{"issue":"1","key":"2024121614380842800_B5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40272-019-00367-1","article-title":"Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management","volume":"22","author":"Henderson","year":"2020","journal-title":"Paediatr Drugs"},{"issue":"16","key":"2024121614380842800_B6","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.3390\/jcm12165366","article-title":"Tuberculosis-associated hemophagocytic lymphohistiocytosis: a review of current literature","volume":"12","author":"Fauchald","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"2024121614380842800_B7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2024121614380842800_B8","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/cid\/ciz1138","article-title":"Tuberculosis disease in children and adolescents on therapy with antitumor necrosis factor-\u0251 agents: a collaborative, multicenter Paediatric Tuberculosis Network European Trials Group (PTBNET) study","volume":"71","author":"Noguera-Julian","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2024121614380842800_B9","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1093\/cid\/ciac717","article-title":"Severe mycobacterial immune reconstitution inflammatory syndrome (IRIS) in advanced human immunodeficiency virus (HIV) has features of hemophagocytic lymphohistiocytosis and requires prolonged immune suppression","volume":"76","author":"Rocco","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2024121614380842800_B10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12969-017-0207-8","article-title":"Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study","volume":"15","author":"Stoll","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"7","key":"2024121614380842800_B11","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden","volume":"52","author":"Askling","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2024121614380842800_B12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/INF.0b013e318239134c","article-title":"Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors","volume":"31","author":"Thampi","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2024121614380842800_B13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/INF.0b013e3182846c4e","article-title":"Paradoxical reaction during tuberculosis treatment in immunocompetent children: clinical spectrum and risk factors","volume":"32","author":"Olive","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2024121614380842800_B14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s15010-018-1226-1","article-title":"Tuberculosis-associated hemophagocytic lymphohistiocytosis with subsequent unmasking cryptococcal immune reconstitution inflammatory syndrome (IRIS) in an HIV-negative man","volume":"47","author":"Geerdes-Fenge","year":"2019","journal-title":"Infection"},{"issue":"1","key":"2024121614380842800_B15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41395-018-0420-1","article-title":"Secondary haemophagocytic syndrome and overlapping immune reconstitution syndrome: life-threatening complications of anti-TNF-\u03b1 treatment for Crohn\u2019s disease","volume":"114","author":"S\u00e1ez-Gonz\u00e1lez","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2024121614380842800_B16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/427941","article-title":"Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis","volume":"40","author":"Garcia Vidal","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2024121614380842800_B17","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/592695","article-title":"Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes","volume":"47","author":"Blackmore","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2024121614380842800_B18","first-page":"bcr0920103376","article-title":"Tuberculosis complicated by immune reconstitution inflammatory syndrome in a patient on anti-TNF\u03b1 therapy for Crohn\u2019s disease","volume":"2011","author":"O\u2019Dowd","year":"2011","journal-title":"BMJ Case Rep"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-067175\/1750476\/peds.2024-067175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-067175\/1750476\/peds.2024-067175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T14:39:14Z","timestamp":1734359954000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/154\/6\/e2024067175\/199848\/Prolonged-Fever-After-the-Treatment-of-Ulcerative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,11,8]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2024-067175","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"article-number":"e2024067175"}}